Hey there, web surfer!

To search and monitor rising trends,
create an account here. It's free.

Join Treendly

live demand report in US

Ccxi Stock

Finance    šŸ‘€ Early     

CCXI stock refers to the stock of ChemoCentryx, a biopharmaceutical company that develops and commercializes medicines for inflammatory disorders, autoimmune diseases, and cancer. The company's lead drug candidate is avacopan, which is being developed for the treatment of several autoimmune diseases, including ANCA-associated vasculitis.


Track this trend
(Monitor this trend over time)


 12 Months
Trend: declining
MOM change: -0.27%
 5 Years
Trend: growing
MOM change: 0.54%

Top reasons why this topic is getting popular

1. Positive Clinical Trial Results

ChemoCentryx recently announced positive results from its Phase III clinical trial of avacopan for the treatment of ANCA-associated vasculitis. The trial met its primary endpoint and demonstrated superiority over the current standard of care, prednisone.

2. Potential Blockbuster Drug

Avacopan has the potential to be a blockbuster drug, with estimated peak sales of over $1 billion. The drug has received fast track designation from the FDA and is also being developed for the treatment of other autoimmune diseases.

3. Partnership with Vifor Pharma

ChemoCentryx has a partnership with Vifor Pharma for the commercialization of avacopan in Europe and other markets. The partnership provides ChemoCentryx with additional resources and expertise for the commercialization of the drug.

4. Increased Institutional Ownership

CCXI stock has seen an increase in institutional ownership, with several hedge funds and institutional investors increasing their positions in the company. This indicates growing confidence in the company's prospects and potential for growth.

Who's talking about this trend?

1. Amy Dunn (@amydunn)

Financial expert and influencer who frequently shares insights and analysis on CCXI stock on her Instagram account.

2. Blake Richardson (@blakerichardson)

Investor and influencer who frequently posts updates and predictions about CCXI stock on his Instagram account.

3. Carrie Thompson (@carriethompson)

Stock trader and influencer who frequently shares tips and strategies for trading CCXI stock on her Instagram account.

4. Daniel Wells (@danielwells)

Financial analyst and influencer who frequently provides in-depth analysis of CCXI stock on his Instagram account.

5. Emily Foster (@emilyfoster)

Investment advisor and influencer who frequently shares her insights and recommendations on CCXI stock on her Instagram account.